{"nct_id":"NCT06312137","title":"A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-04-03","start_date_type":"ACTUAL","primary_completion_date":"2034-02-21","primary_completion_date_type":"ESTIMATED","completion_date":"2034-10-23","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}